Beinaglutide for weight management in Chinese individuals with overweight or obesity: A phase 3 randomized controlled clinical study.

Kang Chen,Li Chen,Zhongyan Shan,Guixia Wang,Shen Qu,Guijun Qin,Xuefeng Yu,Weiquan Xin,Tsung-Han Hsieh,Yiming Mu

Diabetes, obesity & metabolism（2023）

引用 0|浏览9

暂无评分

摘要

Beinaglutide combined with lifestyle intervention resulted in significant and clinically meaningful weight reduction with good tolerance in non-diabetic Chinese individuals with overweight or obesity.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要